How does the USPTO process a patent term extension application?
The USPTO follows a specific process for handling patent term extension applications under 35 U.S.C. 156. According to the MPEP, the process includes the following steps: The USPTO initially determines whether the application is formally complete and whether the patent is eligible for extension. The Director of the USPTO notifies the Secretary of Agriculture or…
Read MoreWhat is the time limit for filing a patent term extension application?
The time limit for filing a patent term extension application is specified in 35 U.S.C. 156(d)(1). According to the MPEP: “An application for the extension of the term of a patent under 35 U.S.C. 156 must be submitted by the owner of record of the patent or its agent within the sixty-day period beginning on…
Read MoreWhat is the scope of rights during the extended patent term under 35 U.S.C. 156?
The scope of rights during the extended patent term under 35 U.S.C. 156 is defined in 35 U.S.C. 156(b). According to the MPEP: “The rights derived from extension of the patent term under 35 U.S.C. 156(a) are defined in 35 U.S.C. 156(b), but are not limited to a claim-by-claim basis. Rather, subsection(a) of 156 indicates…
Read MoreWhat is the purpose of patent term extension under 35 U.S.C. 156?
The purpose of patent term extension under 35 U.S.C. 156 is to compensate patent owners for time lost during the premarket regulatory review process. As stated in the MPEP: “The statute enables the owners of patents on certain human drugs, food or color additives, medical devices, animal drugs, and veterinary biological products to restore to…
Read MoreHow does the Hatch-Waxman Act affect patent infringement related to regulatory approval?
The Hatch-Waxman Act, codified in part as 35 U.S.C. 271(e), provides a safe harbor for certain activities that would otherwise be considered patent infringement. According to the MPEP: “Congress legislatively overruled Roche Products v. Bolar Pharmaceuticals, 733 F.2d 858, 221 USPQ 937 (Fed. Cir. 1984) as to products covered by 35 U.S.C. 271(e) and provided…
Read MoreWhat types of products are eligible for patent term extension?
According to MPEP 2750, the following types of products are eligible for patent term extension under 35 U.S.C. 156: Human drugs Food or color additives Medical devices Animal drugs Veterinary biological products It’s important to note that “Animal drug products which are primarily manufactured through biotechnology are excluded from the provisions of patent term extension.”…
Read More